Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
|Articles|March 22, 2022

Phesi Releases New Data Highlighting Impact from War in Ukraine

New global data analysis from Phesi shows the extent of the impact from the war in Ukraine on clinical development. Phesi analyzed pivotal trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities. The findings show that as of March 16, 2022, there were 65,593 recruiting investigator sites globally in this category. Of these, 2,911 (4.4%) sites were based in Ukraine and Russia, with the majority of pharmaceutical trials currently in Phase III.

Read more about this data release from Phesi here.


Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.